FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040038 [Registered on: 04/02/2022] Trial Registered Prospectively
Last Modified On: 03/02/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial on THAZUTHALAI ILAI CHOORANAM in the management of KUMBAVADHAM( PERIARTHRITIS)  
Scientific Title of Study   A prospective open labelled non randomized phase II clinical trial of THAZHUTHALAI ILAI CHOORANAM in the management of KUMBAVADHAM (PERIARTHRITIS)  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mani bharathi M 
Designation  PG Scholer 
Affiliation  Government Siddha Medical College and Hospital 
Address  PG department of Pothumaruthuvam OP no 10,Government Siddha Medical college and Hospital, Palayamkottai
PG Department of Pothumaruthuvam OP no 10,Government Siddha Medical College and Hospital, Palayamkottai.
Tirunelveli
TAMIL NADU
627002
India 
Phone  9751982937  
Fax    
Email  manibharathibsms@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  ProfDr A Manoharan MDs ph D 
Designation  Professor and HOD  
Affiliation  Government Siddha Medical College and Hospital 
Address  PG Department of Pothumaruthuvam,OP NO 10,Government Siddha Medical College and Hospital, Palayamkottai.
PG Department of Pothumaruthuvam,OP no10 ,Government Siddha Medical College and Hospital, Palayamkottai.
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ProfDr A Manoharan MDs ph D 
Designation  Professor and HOD  
Affiliation  Government Siddha Medical College and Hospital 
Address  PG Department of Pothumaruthuvam,OP no 10,Government Siddha Medical College and Hospital, Palayamkottai.
PG Department of Pothumaruthuvam,OP no 10, Government Siddha Medical College and Hospital, Palayamkottai.
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Source of Monetary or Material Support  
›OPD and IPD facilities and Central Library of Government Siddha Medical College and Hospital palayamkottai, Tirunelveli  
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital  
Address  Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr M Mani bharathi   Government Siddha Medical College and Hospital   PG department of pothumaruthuvam, OP no 10, Palayamkottai, Tirunelveli 627002
Tirunelveli
TAMIL NADU 
9751982937

manibharathibsms@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M750||Adhesive capsulitis of shoulder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil 
Intervention  THAZHUTHALAI ILAI CHOORANAM   2g/twice a day/orally with Hot water,45 days 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patient having main symptoms of shoulder pain, numbness, wasting in the shoulder region and arms, restricted movement of upperlimbs,loss of abduction and forward flexing, stiffness of the shoulder joint
2.Diabetes mellitus
3.patient willing for doing laboratory investigations and X ray, imaging  
 
ExclusionCriteria 
Details  1.Rheumatoid arthritis
2. Ischemical heart disease
3.Hypertension
4. Pregnancy and lactating mother
5.Recent shoulder dislocation
6. Sub acromial bursitis 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
If during treatment or after treatment Redution of the signs and symptoms of
1.shoulder joint pain
2.shoulder stiffness
3.Inability to raise arm
4.Limited shoulder mobility and wasting in shoulder region and arms and numbness
5.Radiating pain down arm
6.Restricted movements of upperlimbs.
7. Loss of abduction and forward flexing and external rotation and achieving better Oxford shoulder score (40-48) 
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
1. To evaluate the biochemical physico-chemical analysis of clinical trail drug
2. To evaluate the antimicrobial activity of trail drug
3.To evaluate the safety profile for acute and subacute toxicity of the trail drug Thazhuthalai ilai chooranam
4. To Evaluate pharmacological analysis of the clinical trail drug
5. To evaluate siddha parameters and modern parameters during the treatment of kumbavadham with trail drug
6. To evaluate the statistical analysis of the clinical trail drug Thazhuthalai ilai chooranam
7. To evaluate the powder of microscopic study and HTPLC of the trail drug 
45days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   12/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective open labelled non randomized phase II clinical trail on Thazhuthalai lllai chooranam in the management of Kumbavadham( Periarthritis). The trail drug will be administered at the dose of 2gm/Twice a day A/F for 45 days along with hot water adjuvant in 40 patients. The trail period of 12 months will be carrying out in Government Siddha  Medical College and Hospital, palayamkottai, Tirunelveli. The primary outcome will be evaluation of therapeutic efficacy of trail drug THAZHUTHALAI ILAI CHOORANAM.  The secondary outcome will be evaluation of siddha parameters, assessment of safety profile of trail drug, assessment of pharmacological and biochemical parameters of trail drug. In case any adverse event (AE)  is noticed and it will be referred to pharmacovigilence department of SCRI.  Further management of patient will be given in OPD facility. 

 
Close